BTCC
/
BTCC Square
/
Global Cryptocurrency
/
AstraZeneca Announces Dual Listing Plan on NYSE and LSE, Shares Rally
AstraZeneca Announces Dual Listing Plan on NYSE and LSE, Shares Rally
8
1
BTCCSquare news:
AstraZeneca's shares gained momentum following its announcement of a dual listing on the New York Stock Exchange and the London Stock Exchange. The pharmaceutical giant aims to broaden its investor base by offering ordinary shares in the U.S., a shift from its previous American depositary receipts (ADRs) on Nasdaq. The MOVE underscores the company's strategic focus on global expansion while maintaining its primary listing on the FTSE 100.
Chair Michel Demaré emphasized the harmonized listing structure as a catalyst for long-term growth, inviting shareholders to vote on the proposal at a November 3 meeting. The decision aligns with AstraZeneca's efforts to mitigate tariff pressures and deepen its U.S. market presence.
By:
